Partial replacement with menhaden oil improves peripheral neuropathy in high-fat-fed low-dose streptozotocin type 2 diabetic rat

Journal of Nutrition and Metabolism

Volumn 2012, Issue , 2012, Pages

  Coppey, Lawrence J ^a   Holmes, Amey ^b   Davidson, Eric P ^a   Yorek, Mark A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; RATTUS;

EID: 84873824806     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2012/950517     Document Type: Article

References (40)

1. De Caterina R., Drug therapy: n-3 fatty acids in cardiovascular disease. The New England Journal of Medicine 2011 364 25 2439 2450 2-s2.0-79959484739 10.1056/NEJMra1008153
2. Kris-Etherton P. M., Harris W. S., Appel L. J., Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002 106 21 2747 2757 2-s2.0-0037137299 10.1161/01.CIR.0000038493.65177.94 (Pubitemid 35364932)
3. Calder P. C., n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clinical Science 2004 107 1 1 11 2-s2.0-3142712905 10.1042/CS20040119 (Pubitemid 38932191)
4. Siscovick D. S., Raghunathan T. E., King I., Weinmann S., Wicklund K. G., Albright J., Bovbjerg V., Arbogast P., Smith H., Kushi L. H., Cobb L. A., Copass M. K., Psaty B. M., Lemaitre R., Retzlaff B., Childs M., Knopp R. H., Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Journal of the American Medical Association 1995 274 17 1363 1367 2-s2.0-0028855987
5. Albert C. M., Campos H., Stampfer M. J., Ridker P. M., Manson J. E., Willett W. C., Jing M., Blood levels of long-chain n-3 fatty acids and the risk of sudden death. The New England Journal of Medicine 2002 346 15 1113 1118 2-s2.0-0037061915 10.1056/NEJMoa012918 (Pubitemid 34984601)
6. Gerbi A., Maixent J. M., Ansaldi J. L., Pierlovisi M., Coste T., Pelissier J. F., Vague P., Raccah D., Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. Journal of Nutrition 1999 129 1 207 213 2-s2.0-0032924798 (Pubitemid 29044783)
7. Pitel S., Raccah D., Gerbi A., Pieroni G., Vague P., Coste T. C., At low doses, a γ -linolenic acid-lipoic acid conjugate is more effective than docosahexaenoic acid-enriched phospholipids in preventing neuropathy in diabetic rats. Journal of Nutrition 2007 137 2 368 372 2-s2.0-33846849048 (Pubitemid 46213451)
8. Dines K. C., Cotter M. A., Cameron N. E., Contrasting effects of treatment with ω -3 and ω -6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Diabetologia 1993 36 11 1132 1138 2-s2.0-0027488137 10.1007/BF00401057 (Pubitemid 23314563)
9. Dines K. C., Cameron N. E., Cotter M. A., Comparison of the effects of evening primrose oil and triglycerides containing γ -linolenic acid on nerve conduction and blood flow in diabetic rats. Journal of Pharmacology and Experimental Therapeutics 1995 273 1 49 55 2-s2.0-0028969751
10. Cameron N. E., Cotter M. A., Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin- diabetic rats. Acta Diabetologica 1994 31 4 220 225 2-s2.0-0028567531 10.1007/BF00571955
11. Gillam M., Noto A., Zahradka P., Taylor C. G., Improved n-3 fatty acid status does not modulate insulin resistance in fa/fa Zucker rats. Prostaglandins Leukotrienes and Essential Fatty Acids 2009 81 5-6 331 339 2-s2.0-71749093924 10.1016/j.plefa.2009.09.008
12. Podolin D. A., Gayles E. C., Wei Y., Thresher J. S., Pagliassotti M. J., Menhaden oil prevents but does not reverse sucrose-induced insulin resistance in rats. American Journal of Physiology 1998 274 3 R840 R848 2-s2.0-0031895769
13. Okuda Y., Mizutani M., Ogawa M., Sone H., Asano M., Asakura Y., Isaka M., Suzuki S., Kawakami Y., Field J. B., Yamashita K., Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus. Journal of Diabetes and its Complications 1996 10 5 280 287 2-s2.0-0030578912 10.1016/1056-8727(95)00081-X (Pubitemid 26326909)
14. Reed M. J., Meszaros K., Entes L. J., Claypool M. D., Pinkett J. G., Gadbois T. M., Reaven G. M., A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000 49 11 1390 1394 2-s2.0-0033761823 10.1053/meta.2000.17721
15. Srinivasan K., Viswanad B., Asrat L., Kaul C. L., Ramarao P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research 2005 52 4 313 320 2-s2.0-23844504364 10.1016/j.phrs.2005.05.004 (Pubitemid 41175991)
16. Davidson E. P., Coppey L. J., Holmes A., Dake B., Yorek M. A., Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications. European Journal of Pharmacology 2011 688 3 497 506
17. Oltman C. L., Davidson E. P., Coppey L. J., Kleinschmidt T. L., Lund D. D., Yorek M. A., Attenuation of vascular/neural dysfunction in zucker rats treated with enalapril or rosuvastatin. Obesity 2008 16 1 82 89 2-s2.0-39449106400 10.1038/oby.2007.19 (Pubitemid 351271954)
18. Coppey L. J., Davidson E. P., Dunlap J. A., Lund D. D., Yorek M. A., Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Experimental Diabesity Research 2000 1 2 131 143 2-s2.0-0034570447
19. Obrosova I. G., Li F., Abatan O. I., Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 2004 53 3 711 720 (Pubitemid 38270641)
20. Beiswenger K. K., Calcutt N. A., Mizisin A. P., Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochemica 2008 110 5 351 362 2-s2.0-48249151602 10.1016/j.acthis.2007.12.004
21. Davidson E. P., Coppey L. J., Calcutt N. A., Oltman C. L., Yorek M. A., Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction. Diabetes/Metabolism Research and Reviews 2010 26 4 306 318 2-s2.0-77952782622 10.1002/dmrr.1088
22. Oltman C. L., Coppey L. J., Gellett J. S., Davidson E. P., Lund D. D., Yorek M. A., Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. American Journal of Physiology 2005 289 1 E113 E122 2-s2.0-21044459538 10.1152/ajpendo.00594.2004 (Pubitemid 40874942)
23. Yorek M. A., Strom D. K., Spector A. A., Effect of membrane polyunsaturation on carrier-mediated transport in cultured retinoblastoma cells: alterations in taurine uptake. Journal of Neurochemistry 1984 42 1 254 261 2-s2.0-0021328866 (Pubitemid 14218045)
24. Yorek M. A., Bohnker R. R., Dudley D. T., Spector A. A., Comparative utilization of n-3 polyunsaturated fatty acids by cultured human Y-79 retinoblastoma cells. Biochimica et Biophysica Acta 1984 795 2 277 285 2-s2.0-0021213834 10.1016/0005-2760(84)90076-6 (Pubitemid 14006615)
25. Kalupahana N. S., Claycombe K., Newman S. J., Stewart T., Siriwardhana N., Matthan N., Lichtenstein A. H., Moustaid-Moussa N., Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. Journal of Nutrition 2010 140 11 1915 1922 2-s2.0-78149275191 10.3945/jn.110.125732
26. González-Périz A., Horrillo R., Ferré N., Gronert K., Dong B., Morán-Salvador E., Titos E., Martínez-Clemente M., López-Parra M., Arroyo V., Clària J., Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω -3 fatty acids: a role for resolvins and protectins. FASEB Journal 2009 23 6 1946 1957 2-s2.0-67649363782 10.1096/fj.08-125674
27. Davidson E. P., Coppey L. J., Holmes A., Yorek M. A., Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin- diabetic rats. European Journal of Pharmacology 2012 677 1-3 180 187
28. Valenzuela R., Videla L. A., The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ration in development of non-alcoholic fatty liver associated with obesity. Food Function 2011 2 11 644 648
29. Siriwardhana N., Kalupahana N. S., Moustaid-Moussa N., Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Advanced Food Nutrition Research 2012 65 211 222
30. Kalupahana N. S., Claycombe K. J., Moustaid-Moussa N., (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Advanced Nutrition 2011 2 4 304 316
31. Tishinsky J. M., Gulli R. A., Mullen K. L., Dyck D. J., Robinson L. E., Fish oil prevents high-saturated fat diet-induced impairments in adiponectin and insulin response in rodent soleus muscle. American Journal of Regulatory Integrative and Comparative Physiology 2012 302 5 R598 R605
32. Siriwardhana N., Kalupahana N. S., Moustaid-Moussa N., Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Advanced Food Nutrition Research 2012 65 211 222
33. Moreno-Aliaga M. J., Lorente-Cebrián S., Martínez J. A., Regulation of adipokine secretion by n-3 fatty acids. Proceedings of the Nutrition Society 2010 69 3 324 332 2-s2.0-77957361839 10.1017/S0029665110001801
34. Takayama F., Nakamoto K., Totani N., Yamanushi T., Kabuto H., Kaneyuki T., Mankura M., Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis. Journal of Oleo Science 2010 59 8 407 414 2-s2.0-77954353061
35. Marsman H. A., Heger M., Kloek J. J., Nienhuis S. L., Van Werven J. R., Nederveen A. J., Ten Kate F. J., Stoker J., Van Gulik T. M., Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by 1H-magnetic resonance spectroscopy in a rat model. Journal of Gastroenterology and Hepatology 2011 26 2 356 363 2-s2.0-78851471191 10.1111/j.1440-1746.2010.06326.x
36. Byrne C. D., Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. Diabetic Medicine 2012 29 7
37. Masterton G. S., Plevris J. N., Hayes P. C., Review article: Omega-3 fatty acids-A promising novel therapy for non-alcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 2010 31 7 679 692 2-s2.0-77649216380 10.1111/j.1365-2036.2010.04230.x
38. Ariel A., Serhan C. N., Resolvins and protectins in the termination program of acute inflammation. Trends in Immunology 2007 28 4 176 183 2-s2.0-33947500462 10.1016/j.it.2007.02.007 (Pubitemid 46467520)
39. Kohli P., Levy B. D., Resolvins and protectins: Mediating solutions to inflammation. British Journal of Pharmacology 2009 158 4 960 971 2-s2.0-70350133786 10.1111/j.1476-5381.2009.00290.x
40. Cortina M. S., He J., Li N., Bazan N. G., Bazan H. E. P., Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Investigative Ophthalmology and Visual Science 2010 51 2 804 810 2-s2.0-77449114133 10.1167/iovs.09-3641